InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: bobshmob post# 89359

Tuesday, 06/30/2020 11:41:01 PM

Tuesday, June 30, 2020 11:41:01 PM

Post# of 232950
Some good outcomes on tocilizumab, but not randomized, as paragraph 2 of the Lancet paper notes: "a non-randomly selected subset of patients also received tocilizumab."

No question, the list of possible storm-treating drugs is narrowing to leronlimab (first with randomized trial results), tocilizumab and lenzilumab. And everyone understands we need storm-treating drugs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News